SCHEMBL2544201

SCHEMBL2544201

CS(=O)(=O)OCC(=O)c1ccc(Cl)cc1

nearest known ligand 0.50

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 2/20 0.50
KMT2A Q03164 4/20 0.46
L3MBTL1 Q9Y468 4/20 0.46
MAPT P10636 4/20 0.46
MEN1 O00255 2/20 0.46
HPGD P15428 1/20 0.46
HSD11B1 P28845 2/20 0.46
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ERCC5 P28715 1/20 0.44
FEN1 P39748 1/20 0.44
LMNA P02545 3/20 0.44
ESR1 P03372 1/20 0.44
ESR2 Q92731 1/20 0.44
KDM4E B2RXH2 1/20 0.44
USP2 O75604 1/20 0.43
ALDH1A1 P00352 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2544347 0.82 PTPN1 (0.48) KMT2AL3MBTL1MEN1HSD11B1NPC1
SCHEMBL2540632 0.81 NPC1 (0.50) GSK3BKMT2AL3MBTL1MAPTMEN1
SCHEMBL2538609 0.81 ALDH1A1 (0.51) MAPTHPGDHSD11B1KDM4EALDH1A1
SCHEMBL2538592 0.81 HDAC3 (0.56) GSK3BMAPTHSD11B1ESR2ALDH1A1
SCHEMBL2536519 0.80 ERCC5 (0.50) KMT2AMAPTMEN1HPGDNPC1
SCHEMBL2541990 0.79 NPC1 (0.51) KMT2AMAPTHPGDNPC1RAB9A
SCHEMBL2542330 0.78 ALDH1A1 (0.55) GSK3BMAPTHSD11B1ALDH1A1
SCHEMBL2536867 0.78 MAPT (0.50) KMT2AMAPTMEN1NPC1RAB9A
SCHEMBL2542303 0.78 KMT2A (0.59) KMT2AL3MBTL1MAPTNPC1RAB9A
SCHEMBL1154812 0.77 GSK3B (0.57) GSK3BKMT2AL3MBTL1MAPTMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8044245-B2 Method for the preparation of optically active 2-sulfonyloxy-1-phenylethanol derivatives KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2011-10-25 US disclosed
US-20100063317-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2010-03-11 US disclosed
WO-2008054155-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES KOREA RESEARCH INSTITUTE OF CHEMICAL TECHNOLOGY (KR) 2008-05-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100063317-A1 METHOD FOR THE PREPARATION OF OPTICALLY ACTIVE 2-SULFONYLOXY-1-PHENYLETHANOL DERIVATIVES FOXO1, ENO1, SULT1A1 GSK3B 1687/4885KMT2A 2462/4885L3MBTL1 4788/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.